Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal fibrotic
pulmonary disease with unknow etiology. Owing to lack of reliable prognostic biomarkers …

Idiopathic pulmonary fibrosis (IPF) is considered to be an ailment of the lungs that cannot be
cured, wherein the lung tissues are characterized by increased thickness and stiffness …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung
disease. It is urgent to identify biomarkers to precisely predict mortality. Methods: Gene …

Background: Increasing evidence has revealed that epithelial–mesenchymal transition
(EMT) and immunity play key roles in idiopathic pulmonary fibrosis (IPF). However …

Background: Idiopathic pulmonary fibrosis (IPF) is one of the most aggressive forms of
interstitial lung diseases (ILDs), marked by an ongoing, chronic fibrotic process within the …

Background The course of disease for patients with idiopathic pulmonary fibrosis (IPF) is
highly heterogeneous. Prognostic models rely on demographic and clinical characteristics …

We previously reported that oxidative stress drives pseudohypoxic hypoxia-inducible factor
(HIF) pathway activation to promote pathogenetic collagen structure-function in human lung …

Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating, and progressive
lung disease that is characterized by fibrosis and respiratory failure. IPF holds high morbidity …

Aim: The aim of this meta-analysis was to investigate associations between idiopathic
pulmonary fibrosis (IPF) and markers of oxidative stress (OS) measured in different …

Patients with idiopathic pulmonary fibrosis (IPF) have a significantly higher prevalence of
lung adenocarcinoma (LUAD) than normal subjects, although the underlying association is …